Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
Novelty
Mechanistic
Druggability
Priority
80%
Importance
Tractability
Market price
50%

Description

While AQP4 polarization correlates with clearance, the debate revealed uncertainty about whether it’s rate-limiting, compensatory, or merely associated. This mechanistic gap affects therapeutic targeting strategies.

Source: Debate session sess_SDA-2026-04-01-gap-v2-18cf98ca (Analysis: SDA-2026-04-01-gap-v2-18cf98ca)

Evidence summary

{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:55.694806+00:00”, “resolution_summary”: “Resolved by hypothesis h-d47c2efa: Targeting the Mechanistic Link Between AQP4 Dysfunction and Ferroptosis Prevents Both Cytotoxic and Vasogenic Edema After Cardiac Arrest. Supporting evidence includes debate sess_SDA-2026-04-12-gap-debate-20260410-113038-57244485_20260412-215703.”, “match_counts”: {“hypothesis_matches”: 4, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-d47c2efa”, “title”: “Targeting the Mechanistic Link Between AQP4 Dysfunction and Ferroptosis Prevents Both Cytotoxic and Vasogenic Edema After Cardiac Arrest”, “score”: 0.24, “reason”: “18 token overlaps; entity overlap: aqp4”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260410-174000-6451afef”, “target_gene”: “AQP4 and ACSL4 (key ferroptosis regulator)”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.803, “confidence_score”: 0.52, “status”: “proposed”, “pubmed_evidence_ids”: [“18281883”, “27080433”, “36516890”, “41776085”, “41933462”]}, {“id”: “h-var-e47f17ca3b”, “title”: “Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance”, “score”: 0.232, “reason”: “17 token overlaps; entity overlap: aqp4”, “analysis_id”: “SDA-2026-04-03-26abc5e5f9f2”, “target_gene”: “SST”, “target_pathway”: “Astrocyte-glymphatic tau clearance via AQP4 and beta-frequency interneuron gating”, “disease”: “Alzheimer’s disease”, “composite_score”: 0.864429, “confidence_score”: 0.8, “status”: “promoted”, “pubmed_evidence_ids”: [“20641372”, “20641809”, “24841123”, “27534393”, “27929004”]}, {“id”: “h-c8ccbee8”, “title”: “Aquaporin-4 Polarization Rescue”, “score”: 0.227, “reason”: “18 token overlaps; entity overlap: aqp4”, “analysis_id”: “sda-2026-04-01-gap-005”, “target_gene”: “AQP4”, “target_pathway”: “Aquaporin-4 water transport / glymphatic clearance”, “disease”: “neurodegeneration”, “composite_score”: 0.7321880000000001, “confidence_score”: 0.68, “status”: “debated”, “pubmed_evidence_ids”: [“16282148”, “17347837”, “22529835”, “24136970”, “31913516”]}, {“id”: “h-807d7a82”, “title”: “SASP-Driven Aquaporin-4 Dysregulation”, “score”: 0.226, “reason”: “19 token overlaps; entity overlap: aqp4”, “analysis_id”: “sda-2026-04-01-gap-013”, “target_gene”: “AQP4”, “target_pathway”: “Aquaporin-4 water transport / glymphatic clearance”, “disease”: “neurodegeneration”, “composite_score”: 0.781579, “confidence_score”: 0.7, “status”: “promoted”, “pubmed_evidence_ids”: [“28456789”, “29876543”, “30987654”, “31234567”, “32345678”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-12-gap-debate-20260410-113038-57244485_20260412-215703”, “title”: “The debate revealed conflicting evidence about whether connexin-43 mediates mitochondrial transfer through gap junctions or tunneling nanotubes. This mechanistic uncertainty undermines therapeutic targeting strategies and requires direct experimental disambiguation.\n\nSource: Debate session sess_SDA-2026-04-01-gap-20260401231108 (Analysis: SDA-2026-04-01-gap-20260401231108)”, “score”: 0.549, “reason”: “12 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-12-gap-debate-20260410-113038-57244485”, “quality_score”: 0.74, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-12-gap-debate-20260410-112848-7ba6c2e1”, “title”: “The debate revealed conflicting evidence about C1q’s role - some studies show it drives synaptic loss while others suggest it facilitates protective amyloid clearance. This fundamental mechanistic uncertainty undermines therapeutic targeting strategies.\n\nSource: Debate session sess_SDA-2026-04-01-gap-v2-691b42f1 (Analysis: SDA-2026-04-01-gap-v2-691b42f1)”, “score”: 0.541, “reason”: “12 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-12-gap-debate-20260410-112848-7ba6c2e1”, “quality_score”: 0.58, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-12-gap-debate-20260410-113010-76c2ddfd”, “title”: “The debate highlighted major uncertainty about whether rodent glymphatic findings translate to humans, with conflicting evidence on circadian patterns. This translation gap is critical for developing sleep-based clearance therapies.\n\nSource: Debate session sess_SDA-2026-04-01-gap-v2-18cf98ca (Analysis: SDA-2026-04-01-gap-v2-18cf98ca)”, “score”: 0.491, “reason”: “10 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-12-gap-debate-20260410-113010-76c2ddfd”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-01-gap-010”, “title”: “What are the mechanisms underlying apoe4 structural biology and therapeutic targeting strategies?”, “score”: 0.472, “reason”: “6 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-01-gap-010”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: “SDA-2026-04-01-gap-010”, “target_artifact_type”: “analysis”}, {“id”: “sess_SDA-2026-04-16-gap-debate-20260410-113104-a13caf2e_20260416-135601”, “title”: “The skeptic raised evidence that APOE4 carriers show enhanced cholesterol synthesis, suggesting the lipid binding deficit may be compensatory rather than harmful. This fundamental mechanistic question affects all lipid-based therapeutic approaches.\n\nSource: Debate session sess_SDA-2026-04-01-gap-auto-fd6b1635d9 (Analysis: SDA-2026-04-01-gap-auto-fd6b1635d9)”, “score”: 0.42, “reason”: “9 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-16-gap-debate-20260410-113104-a13caf2e”, “quality_score”: 0.71, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}